Low-grade inflammation in young adults exposed to intrauterine hyperglycemia

Louise Kelstrup1, Tine Dalsgaard Clausen, Elisabeth R Mathiesen

  • 1Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. louisekelstrup@dadlnet.dk

Insights

Maternal overweight, not fetal hyperglycemia exposure, is linked to adult offspring inflammation. This study found no association between high blood sugar during pregnancy and offspring

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Inflammation Research

Background:

  • Intrauterine hyperglycemia, including gestational diabetes mellitus (GDM), may impact offspring's long-term health.
  • Low-grade inflammation, indicated by interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP), is linked to metabolic diseases.

Purpose of the Study:

  • To examine the relationship between fetal exposure to intrauterine hyperglycemia and plasma IL-6 and hs-CRP levels in adult offspring.
  • To differentiate the impact of maternal hyperglycemia from maternal overweight on offspring's inflammatory markers.

Main Methods:

  • Studied 597 adult offspring (18-27 years) categorized by maternal history: GDM, GDM risk factors, type 1 diabetes, or background population.
  • Measured offspring plasma IL-6, hs-CRP, fasting glucose, and anthropometrics.
  • Utilized oral glucose tolerance tests to assess glucose metabolism.

Main Results:

  • No significant association was found between intrauterine hyperglycemia exposure and offspring IL-6 or hs-CRP levels.
  • Maternal overweight (BMI ≥ 25 kg/m²) was positively associated with offspring IL-6 and hs-CRP (p=0.003).
  • Offspring with overweight or abnormal glucose tolerance exhibited higher IL-6 and hs-CRP levels (p<0.007).

Conclusions:

  • Maternal overweight is a significant factor associated with low-grade inflammation in adult offspring.
  • Exposure to intrauterine hyperglycemia was not found to be associated with increased IL-6 and hs-CRP levels in adult offspring.
  • These findings highlight the distinct roles of maternal metabolic status and hyperglycemia in offspring's long-term inflammatory profiles.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...